Gastroparesis Trial, Recruiting NCT07287943 Sponsor: Viral N. Shah Condition: Gastroparesis
Back to Gastroparesis

Gastroparesis Trial, Recruiting

NCT07287943
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with Type 1 diabetes for at least 12 months, and your insulin routine has been stable for at least 2 months
  • Your HbA1c (a measure of average blood sugar over roughly 3 months) is 8.0% or higher
  • You have been diagnosed with gastroparesis (a condition where the stomach empties more slowly than normal), as defined by the National Institutes of Health
  • You are willing to use a Medtronic 780G insulin pump system with a Simplera continuous glucose monitor (CGM)
  • You are able to give your informed consent before any study activities begin
  • If you are placed in the usual care group and already use an insulin pump, you are willing to use it in manual mode only for the whole study

Who may not be able to join:

  • You are under 18 years old
  • You currently use inhaled insulin (brand name Afrezza)
  • You use any blood sugar-lowering medications other than insulin at the time of screening
  • You are currently pregnant, breastfeeding, or planning to become pregnant
  • You are currently using steroid medications continuously for 2 weeks or more, or expect to need long-term steroid treatment (more than 4 weeks in a row) during the study
  • You have a history of a blockage at the stomach outlet or other physical abnormalities in your digestive tract
  • Your kidney function is significantly reduced (eGFR below 30) or you are currently on dialysis (confirm with trial site)
  • You have had a severe hypoglycemic episode (dangerously low blood sugar requiring help from another person) in the past 3 months
  • You have had two or more episodes of diabetic ketoacidosis (DKA) requiring a hospital stay in the past 12 months
  • You have a serious medical condition such as severe heart disease, cancer, or chronic liver disease, or a significant mental health condition that the study doctors feel makes participation unsuitable
  • You have taken any experimental/investigational drugs within a recent period before screening (confirm timeframe with trial site)
  • You currently use cannabis or have a history of cannabinoid hyperemesis syndrome (severe vomiting linked to cannabis use)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 317-278-6017

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Viral N. Shah
Registry
ClinicalTrials.gov
Start date
9 February 2026
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time in Range (70-180 mg/dL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov